The effect of bovine somatotropin (bST) administration on reproduction, progesterone concentration during lactation and LH secretion during estrus, in dairy ewes.
Twenty-two polytocous lactating Chios ewes were used to test the effects of bovine somatotropin (bST) on reproduction, progesterone concentration and LH secretion during estrus. Half of the ewes were injected every second week with 160 mg bST in a prolonged release vehicle, from the fifth day post partum until the end of lactation, while the remaining ones were used as controls. All animals were fed the same amount of ration. Supplementation with bST resulted in an increase of milk production (P<0.05) and an insignificant trend for delayed resumption of normal estrous cycles. Although there were no differences between groups, there was also a tendency for the bST group to display lower progesterone concentrations during the first three fortnights after the onset of normal estrous cycles and higher ones during the last three fortnights of the experiment, compared with the control group. Duration of the first normal luteal phase after delivery of the bST group was found to be shorter compared with the control group (P<0.05). After estrous synchronization the bST group showed a shorter estrus compared with the control group (P<0.05). Average and baseline LH concentrations during synchronized estrous in the bST group was lower (P<0.001) compared with the control group. Additionally, the conception rate did not differ between the two groups. This study supports the concept that the beneficial effects of bST treatment on milk production outweigh the potential deleterious effects on reproduction.
Brozos
C N
CN
Clinic of Obstetrics and AI, Faculty of Veterinary Medicine, Aristotle University of Thessaloniki, Macedonia, Greece. drbrozos@yahoo.com
Saratsis
P
P
Boscos
C
C
Kyriakis
S C
SC
Alexopoulos
C
C
D000818:Animals; D002417:Cattle; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D004973:Estrus Synchronization / Q000187:drug effects / Q000502:physiology; D005260:Female; D013006:Growth Hormone / Q000494:pharmacology*; D007279:Injections, Subcutaneous / Q000662:veterinary; D007315:Insemination, Artificial / Q000662:veterinary; D007774:Lactation / Q000187:drug effects*; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D008892:Milk / Q000378:metabolism; D011247:Pregnancy; D011374:Progesterone / Q000097:blood*; D011897:Random Allocation; D012098:Reproduction / Q000187:drug effects*; D012756:Sheep / Q000502:physiology*
D011374:Progesterone; D007986:Luteinizing Hormone; D013006:Growth Hormone